论文信息 - Screening for Cardiovascular Risks — In Whose Interest do we Act? - 字舞流文

Screening for Cardiovascular Risks — In Whose Interest do we Act?

[1] E. Rapaport,et al. Management of primary hyperlipidemia. , 1995, The New England journal of medicine.

[2] C. Normand,et al. Strategies for reducing coronary risk factors in primary care: which is most cost effective? , 1995, BMJ.

[3] F. Song,et al. Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.

[4] D. Hensrud,et al. Clinical Preventive Medicine , 1993 .

[5] G. Rose,et al. Alcohol and Drugs: the Scottish Experience , 1993 .

[6] S. Woolf. Elevated Serum Cholesterol in Asymptomatic Adults , 1990 .

[7] A. Linton. Cholesterol: consensus and controversy. , 1990, Journal of clinical epidemiology.

[8] M. Claeson,et al. Ridding the world of hydroxyquinolines. , 1989, BMJ.

[9] T. Marteau,et al. Psychological costs of screening. , 1989, BMJ.

[10] B. Littenberg,et al. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. , 1989, Annals of internal medicine.

[11] D. Gau. MILD HYPERTENSION: IS THERE PRESSURE TO TREAT? , 1988 .

[12] M. Oliver,et al. Reducing cholesterol does not reduce mortality. , 1988, Journal of the American College of Cardiology.

[13] S. Jachuck,et al. The effect of hypotensive drugs on the quality of life. , 1982, The Journal of the Royal College of General Practitioners.

[14] R B Haynes,et al. Increased absenteeism from work after detection and labeling of hypertensive patients. , 1978, The New England journal of medicine.